Navigation Links
Compound In Grapes And Red Wine To Counter Alzheimer's Disease

Recent research shows that resveratrol, a compound found in grapes and red wine, lowers the levels of the amyloid-beta peptides, which cause the telltale senile plaques of Alzheimer's disease. //

Wine is enriched in antioxidant compounds with potential neuroprotective activities. Resveratrol is an antioxidant, a group of plant-based chemicals being widely studied for their health benefits. It is a natural polyphenol occurring in abundance in several plants, including grapes, berries and peanuts, and is found in high concentrations in red wines.

The researchers from the Litwin-Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders in Manhasset, New York administered resveratrol to cells, which produce human amyloid-beta and tested the compound's effectiveness by monitoring amyloid-beta levels inside and outside the cells. They found that levels of amyloid-beta in the treated cells were much lower than those in untreated cells.

Their findings appear in the November issue of the Journal of Biological Chemistry. The researchers believe the compound acts by stimulating the degradation of amyloid-beta peptides by the proteasome, a barrel-shaped multi-protein complex that can specifically digest proteins into short polypeptides and amino acids.

However, the authors stress that eating grapes may not be a cure for Alzheimer's disease, because natural resveratrol is unstable. That makes it hard to get protection from eating grapes or drinking wine.

The authors assert that these findings demonstrate a proteasome-dependent anti-amyloidogenic activity of resveratrol and suggest that this natural compound has a therapeutic potential in Alzheimer's disease.


'"/>




Page: 1

Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Sugars Could Contain Key Cancer Inhibiting Compounds
8. Compound From Cyanobacterium Can Fight Alzheimer’
9. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
10. Compounds in Licorice Can Fight Tooth Decay
11. New Compound Offers Hope In Liver Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Students interested in video ... Awareness Scholarship competition., The winner will earn a $1,000 scholarship and have his or ... Feb. 1, and the deadline is May 31, with the winner announced on June ...
(Date:1/19/2017)... Fla. (PRWEB) , ... January 19, 2017 , ... ... of faculty and staff members in 2017 who are passionate about making a ... Founded in 1994 and headquartered in Tampa, UMA, a nonprofit healthcare educational institution, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... financial planning services to communities throughout eastern Georgia, is embarking on a charity ... , Heart disease kills more Americans every year than anything else, yet risk ...
(Date:1/19/2017)... , ... January 19, 2017 , ... St. Catherine’s Village ... , Siena Center is a skilled nursing facility on the grounds of the St. ... rooms. It recently was voted the best nursing home in Mississippi for the second ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... at Reproductive Medicine Associates of Connecticut (RMACT) have earned “Top Doctor” awards. Dr. ... Dr. Shaun Williams have each been chosen by their peers for the 2017 ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: